---
title: "MediWound Q2 2026 earnings preview"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295700741.md"
description: "MediWound (MDWD) is set to report Q2 2026 earnings on August 13th. Consensus estimates project an EPS of -$0.77, a 37.4% year-over-year improvement, and revenue of $2.59 million, down 54.6% YoY. Historically, the company has beaten EPS estimates 38% of the time and revenue estimates 75% of the time over the past two years."
datetime: "2026-08-12T19:34:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295700741.md)
  - [en](https://longbridge.com/en/news/295700741.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295700741.md)
generator: "portal-rs"
---

# MediWound Q2 2026 earnings preview

MediWound (MDWD) is scheduled to announce Q2 earnings results on Thursday, August 13th, before market open. The consensus EPS Estimate is -$0.77 (+37.4% Y/Y) and the consensus Revenue Estimate is $2.59M (-54.6% Y/Y). Over the last 2 years, MDWD has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time. Over the last ...

### Related Stocks

- [MDWD.US](https://longbridge.com/en/quote/MDWD.US.md)

## Related News & Research

- [MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates](https://longbridge.com/en/news/296027865.md)
- [Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/296009139.md)
- [MediWound (NASDAQ:MDWD) Issues Earnings Results](https://longbridge.com/en/news/295866831.md)
- [MediWound (MDWD) Expected to Release Earnings on Thursday](https://longbridge.com/en/news/295071377.md)
- [MDWD: Validated enzymatic therapies drive strong growth, targeting $1B+ peak sales in chronic wounds](https://longbridge.com/en/news/295787113.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**